Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Intervertebral Discs Bioengineered in the Laboratory

By HospiMedica International staff writers
Posted on 29 Jan 2009
A new collaboration between U.S. More...
physician-scientists has led to the creation of bioengineered intervertebral discs (IVDs) in the laboratory, for transplantation into the spines of rats.

Each year, 40-60% of adults suffer from chronic back pain in the United States alone. For patients diagnosed with severe degenerative disc disease, neurosurgeons must perform surgery called discectomy--removing the IVD--followed by a fusion of the vertebrate bones to stabilize the spine. Even after all that effort, the patient's back, in all probability, will not feel the same as before their injury.

To create new spine discs, Drs. Roger Härtl and Lawrence Bonassar from Weill Cornell Medical College (New York, NY, USA) and basic science researchers at Cornell University (Ithaca, NY, USA) are using cells from IVD tissue of human patients who have had their spinal discs removed. Dr. Härtl is a well-known neurologic surgeon at New York-Presbyterian Hospital/Weill Cornell Medical Center (New York, NY, USA), and assistant professor of neurological surgery at Weill Cornell Medical College, and Dr. Bonassar is an associate professor in the departments of biomedical engineering and mechanical and aerospace engineering at Cornell University.

In the process, Dr. Härtl harvests tissue from the removed discs and sends it to Dr. Bonassar. Cells are then isolated from this tissue and grown in an incubator that simulates the environment in the body. Once developed, they are placed on a bioengineered scaffold, enabling the assembly of the cells and scaffold into an IVD-shaped implant. The researchers then surgically implant the discs inside a rat's spine in order to see how the tissue reacts to the mechanical and biologic demands. So far, results are promising.

The researchers hope to soon evaluate the bioengineered discs in human subjects in a clinical trial, so that someday individuals can receive spare parts for their aging or injured backs.

Related Links:
Weill Cornell Medical College


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mobile X-Ray System
K4W
Bipolar Coagulation Generator
Aesculap
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.